The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting is being held 30th May – 3rd June in Chicago, IL, USA. Under the theme ‘Driving Knowledge to Action: Building a Better Future,’ #ASCO25 is set to welcome 40,000 oncology professionals, researchers and advocates from around the globe. As the oncology community gathers together, the convergence of innovative research, expert insights and collaborative spirit promises to drive meaningful advancements in cancer care.
Stay tuned for more updates as the meeting approaches! touchONCOLOGY are thrilled to be speaking with leading experts across the field, and keep an eye out on our website and social media for the latest news, updates and Q&As fresh from Chicago!
View the 3,000 abstracts here
Preview – key themes
- Translational research
- Precision medicine
- Health equity
- Artificial Intelligence
- Global collaboration
The meeting will feature over 5,000 abstracts, with more than 450 oral presentations across 24 Oral Abstract Sessions and 24 Rapid Oral Abstract Sessions, along with 13 Clinical Science Symposia.
Highlights include
- Presidential Address from Dr Robin Zon
- Karnofsky Award Lecturer: Recognizing outstanding contributions to cancer research and care.
- Plenary Sessions
- ASCO Voices: Presenting diverse perspectives and personal stories in oncology
- Joint Sessions: Collaborations with AACR and ESMO to discuss global oncology advancements
The American Society of Clinical Oncology (ASCO) is the world’s leading professional organization for physicians and oncology professionals dedicated to advancing cancer care. Founded in 1964, ASCO represents nearly 50,000 members worldwide and plays a central role in driving clinical research, setting standards for cancer treatment, and advocating for policies that improve patient access to high-quality care. Through its flagship journal Journal of Clinical Oncology, influential clinical guidelines, and annual meetings that showcase the latest scientific advances, ASCO fosters global collaboration and innovation in the fight against cancer.
For more information, visit the official ASCO website.
Disclosure: This article was created by the touchONCOLOGY team utilizing AI as an editorial tool (ChatGPT (GPT-4o) [Large language model]. https://chat.openai.com/chat.) The content was developed and edited by human editors. No funding was received in the publication of this article.
SIGN UP to touchONCOLOGY!
Join our global community today for access to thousands of peer-reviewed articles, expert insights, and learn-on-the-go education across 150+ specialties, plus concise email updates and newsletters so you never miss out.
